REPLIGEN CORP - COMMON STOCK (RGEN)

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / COMMON STOCK
Shares outstanding
56,222,082
Total 13F shares
53,762,692
Share change
+410,613
Total reported value
$9,049,151,613
Put/Call ratio
55%
Price per share
$168.36
Number of holders
438
Value change
+$69,185,811
Number of buys
199
Number of sells
199

Institutional Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q1 2023

As of 31 Mar 2023, REPLIGEN CORP - COMMON STOCK (RGEN) was held by 438 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 53,762,692 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, STATE STREET CORP, SANDS CAPITAL MANAGEMENT, LLC, WELLINGTON MANAGEMENT GROUP LLP, BROWN CAPITAL MANAGEMENT LLC, Invesco Ltd., and Artisan Partners Limited Partnership. This page lists 442 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.